Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy For Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy For Cancermarket, defines the market attractiveness level of Gene Therapy For Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy For Cancer industry, describes the types of Gene Therapy For Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy For Cancer market and the development prospects and opportunities of Gene Therapy For Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy For Cancer market in Chapter 13.
By Player:
AUSTRIANOVA
Arcellx
American Gene Technologies
Cellectis
Alphavax
Chimeron
GLIEAD
REGENXBIO
Autolus
By Type:
Rb Gene
P53 Gene
APC Gene
NF1 Gene
Others
By End-User:
Cancer Treatment
Tissue Repair
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy For Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy For Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy For Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy For Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy For Cancer Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy For Cancer Consumption (2017-2022)
-
7.2 United States Gene Therapy For Cancer Consumption (2017-2022)
-
7.3 Europe Gene Therapy For Cancer Consumption (2017-2022)
-
7.4 China Gene Therapy For Cancer Consumption (2017-2022)
-
7.5 Japan Gene Therapy For Cancer Consumption (2017-2022)
-
7.6 India Gene Therapy For Cancer Consumption (2017-2022)
-
7.7 South Korea Gene Therapy For Cancer Consumption (2017-2022)
8 Region and Country-wise Gene Therapy For Cancer Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy For Cancer Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy For Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy For Cancer Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy For Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy For Cancer Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy For Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy For Cancer Consumption Forecast (2022-2028)
9 Global Gene Therapy For Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy For Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rb Gene Consumption and Growth Rate (2017-2022)
-
9.1.2 Global P53 Gene Consumption and Growth Rate (2017-2022)
-
9.1.3 Global APC Gene Consumption and Growth Rate (2017-2022)
-
9.1.4 Global NF1 Gene Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy For Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Tissue Repair Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy For Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy For Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rb Gene Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global P53 Gene Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global APC Gene Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global NF1 Gene Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy For Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Tissue Repair Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy For Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy For Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy For Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy For Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy For Cancer Market Competitive Analysis
-
14.1 AUSTRIANOVA
-
14.1.1 AUSTRIANOVA Company Details
-
14.1.2 AUSTRIANOVA Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AUSTRIANOVA Gene Therapy For Cancer Product and Service
-
14.2 Arcellx
-
14.2.1 Arcellx Company Details
-
14.2.2 Arcellx Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Arcellx Gene Therapy For Cancer Product and Service
-
14.3 American Gene Technologies
-
14.3.1 American Gene Technologies Company Details
-
14.3.2 American Gene Technologies Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 American Gene Technologies Gene Therapy For Cancer Product and Service
-
14.4 Cellectis
-
14.4.1 Cellectis Company Details
-
14.4.2 Cellectis Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cellectis Gene Therapy For Cancer Product and Service
-
14.5 Alphavax
-
14.5.1 Alphavax Company Details
-
14.5.2 Alphavax Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Alphavax Gene Therapy For Cancer Product and Service
-
14.6 Chimeron
-
14.6.1 Chimeron Company Details
-
14.6.2 Chimeron Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Chimeron Gene Therapy For Cancer Product and Service
-
14.7 GLIEAD
-
14.7.1 GLIEAD Company Details
-
14.7.2 GLIEAD Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GLIEAD Gene Therapy For Cancer Product and Service
-
14.8 REGENXBIO
-
14.8.1 REGENXBIO Company Details
-
14.8.2 REGENXBIO Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 REGENXBIO Gene Therapy For Cancer Product and Service
-
14.9 Autolus
-
14.9.1 Autolus Company Details
-
14.9.2 Autolus Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Autolus Gene Therapy For Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy For Cancer
-
Figure Gene Therapy For Cancer Picture
-
Table Global Gene Therapy For Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy For Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy For Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy For Cancer Consumption by Country (2017-2022)
-
Figure United States Gene Therapy For Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy For Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy For Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy For Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy For Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy For Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy For Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy For Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy For Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy For Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy For Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy For Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy For Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rb Gene Consumption and Growth Rate (2017-2022)
-
Figure Global P53 Gene Consumption and Growth Rate (2017-2022)
-
Figure Global APC Gene Consumption and Growth Rate (2017-2022)
-
Figure Global NF1 Gene Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Tissue Repair Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rb Gene Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global P53 Gene Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global APC Gene Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NF1 Gene Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tissue Repair Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy For Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy For Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table AUSTRIANOVA (Foundation Year, Company Profile and etc.)
-
Table AUSTRIANOVA Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table AUSTRIANOVA Gene Therapy For Cancer Product and Service
-
Table Arcellx (Foundation Year, Company Profile and etc.)
-
Table Arcellx Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arcellx Gene Therapy For Cancer Product and Service
-
Table American Gene Technologies (Foundation Year, Company Profile and etc.)
-
Table American Gene Technologies Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table American Gene Technologies Gene Therapy For Cancer Product and Service
-
Table Cellectis (Foundation Year, Company Profile and etc.)
-
Table Cellectis Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellectis Gene Therapy For Cancer Product and Service
-
Table Alphavax (Foundation Year, Company Profile and etc.)
-
Table Alphavax Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alphavax Gene Therapy For Cancer Product and Service
-
Table Chimeron (Foundation Year, Company Profile and etc.)
-
Table Chimeron Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chimeron Gene Therapy For Cancer Product and Service
-
Table GLIEAD (Foundation Year, Company Profile and etc.)
-
Table GLIEAD Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table GLIEAD Gene Therapy For Cancer Product and Service
-
Table REGENXBIO (Foundation Year, Company Profile and etc.)
-
Table REGENXBIO Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table REGENXBIO Gene Therapy For Cancer Product and Service
-
Table Autolus (Foundation Year, Company Profile and etc.)
-
Table Autolus Gene Therapy For Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Autolus Gene Therapy For Cancer Product and Service
-
